SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.279
EU - Europa 6.393
AS - Asia 4.276
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 13
AF - Africa 6
Totale 34.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.238
CN - Cina 2.413
UA - Ucraina 1.642
IT - Italia 1.318
DE - Germania 1.187
TR - Turchia 1.009
GB - Regno Unito 641
SG - Singapore 549
SE - Svezia 422
PL - Polonia 409
FI - Finlandia 365
BE - Belgio 80
FR - Francia 70
ID - Indonesia 70
RU - Federazione Russa 59
CZ - Repubblica Ceca 55
HK - Hong Kong 54
NL - Olanda 46
VN - Vietnam 45
IN - India 39
CA - Canada 36
IR - Iran 36
AU - Australia 19
JP - Giappone 18
RO - Romania 16
CH - Svizzera 14
IE - Irlanda 13
EU - Europa 12
KR - Corea 11
ES - Italia 9
GR - Grecia 9
TW - Taiwan 7
DK - Danimarca 6
NZ - Nuova Zelanda 6
PE - Perù 6
GE - Georgia 5
NO - Norvegia 5
PT - Portogallo 5
AL - Albania 4
BG - Bulgaria 4
BR - Brasile 4
IL - Israele 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
HU - Ungheria 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DZ - Algeria 2
KE - Kenya 2
MK - Macedonia 2
MY - Malesia 2
TH - Thailandia 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
HN - Honduras 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 34.006
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.987
Fairfield 2.928
Chandler 1.929
Houston 1.868
Jacksonville 1.835
Ashburn 1.414
Ann Arbor 1.407
Seattle 1.174
Wilmington 1.105
Cambridge 962
Izmir 629
Nanjing 570
Ferrara 450
Princeton 436
Warsaw 407
Boardman 396
Beijing 383
New York 323
Singapore 308
San Diego 269
Shanghai 191
Milan 187
Dearborn 173
Nanchang 171
Shenyang 169
Bremen 162
Hebei 120
Jiaxing 110
Los Angeles 106
Tianjin 105
Falls Church 104
Changsha 91
Redwood City 86
Jinan 81
Norwalk 72
Brussels 71
San Mateo 71
Jakarta 67
Kunming 66
Mountain View 65
Düsseldorf 51
London 50
Auburn Hills 49
Brno 48
Zhengzhou 45
Dong Ket 44
Addison 42
Hong Kong 42
Des Moines 41
Munich 39
Guangzhou 37
Ningbo 37
Rome 32
Orange 31
Helsinki 29
Hangzhou 27
Taizhou 27
Washington 26
Verona 25
Bologna 23
Augusta 22
Chicago 21
Leawood 21
Indiana 19
Monmouth Junction 19
Padova 19
Redmond 18
Philadelphia 17
Toronto 17
Ardabil 15
Fuzhou 14
Hefei 13
Mcallen 13
Lanzhou 12
Tappahannock 12
Florence 11
Hounslow 11
Haikou 10
Montréal 10
Napoli 10
Piemonte 9
Amsterdam 8
Catania 8
Changchun 8
Paris 8
Andover 7
Ferrara di Monte Baldo 7
Frankfurt am Main 7
Hyderabad 7
Kilburn 7
Pavia 7
San Francisco 7
Taiyuan 7
Tokyo 7
Wuhan 7
Abdullah 6
Chengdu 6
Dublin 6
Olomouc 6
Walnut 6
Totale 25.238
Salva come PNG Salva come JPEG
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 302
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 215
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 189
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 180
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 179
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 170
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 167
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 159
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 158
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 157
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 155
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 149
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 146
Hemostasis biomarkers in multiple sclerosis 144
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 143
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 142
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 141
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 140
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 138
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 137
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 137
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 136
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 135
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 133
Chronic sleep deprivation markedly reduces coagulation factor VII expression 130
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 130
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 129
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 127
null 125
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 125
Characterization of a deleted Y chromosome in a male with Turner stigmata 125
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 124
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 123
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 122
null 121
Taqi polymorphism at the human coagulation factor XII locus (F12) 121
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 120
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 120
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. 119
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 119
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 119
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 118
Plasma levels of soluble NCAM in multiple sclerosis 118
Circadian rhythms in mouse blood coagulation 117
Better or worse than the original 117
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 116
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 116
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 116
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 116
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 115
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 115
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 114
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 114
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B 114
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 113
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 113
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 113
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 112
Membrane binding and anticoagulant properties of protein S natural variants 112
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 112
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 112
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 111
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 111
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 111
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 111
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 110
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 110
null 109
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 109
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 109
Partial gene deletion in a family with factor X deficiency 109
Detection and characterization of polymorphic markers in the factor-VII gene. 108
PvuII RFLP inside the human estrogen receptor gene 108
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 108
Rescue of coagulation factor VII function by the U1+5A snRNA 107
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 106
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 106
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 106
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 106
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 105
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis 105
RNA-based therapeutic approaches for coagulation factor deficiencies 105
Assignment of human coagulation factor XII (fXII) to chromosome 5 by cDNA hybridization to DNA from somatic cell hybrids 104
Factor VII mutant V154G models a zymogen-like form of factor VIIa 104
Factor IX propeptide mutation and life threatening bleeding 104
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 104
Phytochemical Analysis and Cytotoxicity Towards Multidrug-Resistant Leukemia Cells of Essential Oils Derived from Lebanese Medicinal Plants 104
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 103
null 103
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 103
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 103
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 103
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 103
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 103
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 103
An underestimated combination of opposites resulting in enhanced thrombotic tendency 102
Functional properties of factor V and factor Va encoded by the R2-gene 102
Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength 102
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 102
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 102
Totale 12.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 881
Totale 150.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.208 0 242 262 1.057 489 918 679 742 579 797 291 152
2020/20215.461 458 420 291 642 185 500 331 627 180 801 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/2025397 266 131 0 0 0 0 0 0 0 0 0 0
Totale 34.667